FR2751646B1 - Phenoxypropanolamine a action antagoniste beta3-adrenergique - Google Patents

Phenoxypropanolamine a action antagoniste beta3-adrenergique

Info

Publication number
FR2751646B1
FR2751646B1 FR9609203A FR9609203A FR2751646B1 FR 2751646 B1 FR2751646 B1 FR 2751646B1 FR 9609203 A FR9609203 A FR 9609203A FR 9609203 A FR9609203 A FR 9609203A FR 2751646 B1 FR2751646 B1 FR 2751646B1
Authority
FR
France
Prior art keywords
phenoxypropanolamine
beta3
antagonist
adrenergic action
adrenergic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9609203A
Other languages
English (en)
Other versions
FR2751646A1 (fr
Inventor
Domenico Badone
Roberto Cecchi
Tiziano Croci
Umberto Guzzi
Luciano Manara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA filed Critical Sanofi SA
Priority to FR9609203A priority Critical patent/FR2751646B1/fr
Priority to PCT/FR1997/001360 priority patent/WO1998003485A1/fr
Priority to AU38529/97A priority patent/AU3852997A/en
Publication of FR2751646A1 publication Critical patent/FR2751646A1/fr
Application granted granted Critical
Publication of FR2751646B1 publication Critical patent/FR2751646B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR9609203A 1996-07-23 1996-07-23 Phenoxypropanolamine a action antagoniste beta3-adrenergique Expired - Fee Related FR2751646B1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR9609203A FR2751646B1 (fr) 1996-07-23 1996-07-23 Phenoxypropanolamine a action antagoniste beta3-adrenergique
PCT/FR1997/001360 WO1998003485A1 (fr) 1996-07-23 1997-07-22 PHENOXYPROPANOLAMINES A ACTION ANTAGONISTE β3-ADRENERGIQUE
AU38529/97A AU3852997A (en) 1996-07-23 1997-07-22 Phenoxypropanolamines having beta3-adrenergic antagonist activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9609203A FR2751646B1 (fr) 1996-07-23 1996-07-23 Phenoxypropanolamine a action antagoniste beta3-adrenergique

Publications (2)

Publication Number Publication Date
FR2751646A1 FR2751646A1 (fr) 1998-01-30
FR2751646B1 true FR2751646B1 (fr) 1999-01-22

Family

ID=9494337

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9609203A Expired - Fee Related FR2751646B1 (fr) 1996-07-23 1996-07-23 Phenoxypropanolamine a action antagoniste beta3-adrenergique

Country Status (3)

Country Link
AU (1) AU3852997A (fr)
FR (1) FR2751646B1 (fr)
WO (1) WO1998003485A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0102407D0 (en) 2001-01-31 2001-03-14 Glaxo Group Ltd Process
US7709677B2 (en) 2001-01-31 2010-05-04 Glaxosmithkline Llc Process of preparing arylethanoldiamines
MA44037B1 (fr) 2016-06-06 2020-03-31 Arena Pharm Inc Modulateurs du récepteur adrénergique bêta 3 utile dans le traitement ou la prévention de troubles associés à ceux-ci

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556668A (en) * 1983-07-15 1985-12-03 American Hospital Supply Corporation Ethylenediamine derivatives of aryloxypropanolamine aryl esters having various medicinal properties
AU2737295A (en) * 1994-06-09 1996-01-04 Glaxo Group Limited Phenethanolamine derivatives and their use as atypical beta-adrenoceptor agonists

Also Published As

Publication number Publication date
AU3852997A (en) 1998-02-10
WO1998003485A1 (fr) 1998-01-29
FR2751646A1 (fr) 1998-01-30

Similar Documents

Publication Publication Date Title
ID18090A (id) Mikrokapsul menggunakan iminooksadiazinadiona poliisosianat
ID22500A (id) Turunan sulfonamida
ID24430A (id) Turunan-turunan benzamidina
ATE208395T1 (de) Thiophenopyrimidine
NO985766L (no) B°lgeenergiomformer
ID19474A (id) Turunan tiazola
ATE262512T1 (de) Arylalkanoylpyridazine
ATE208773T1 (de) Chinoxalindione
DE69708027T2 (de) Auswahlanordnung
ID18095A (id) Turunan tetrahidrokinolin
ITRM970243A0 (it) Avviatore a contraccolpo
ATE353652T1 (de) Östroprogestatives antikonzeptionsmittel
ID17169A (id) Untaian ritsleting rajutan
FR2768046B1 (fr) Cotyle a bouchons
ID17167A (id) Untaian ritsleting rajutan
ID16013A (id) PEROLEHAN ε-KAPROLAKTAM
FR2751646B1 (fr) Phenoxypropanolamine a action antagoniste beta3-adrenergique
DE29604226U1 (de) Schutzplankenanordnung
BR9711681A (pt) Novos m-todos
NO992357D0 (no) B°yekonstruksjon
NO992480L (no) Line
ID17945A (id) Lemari es
KR970050767U (ko) 출입식 책걸상
DE9401753U1 (de) Dichtungsbahn
FR2759854B1 (fr) Desileuse-pailleuse a trappes

Legal Events

Date Code Title Description
ST Notification of lapse